Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SENATE MEDICARE BILL WOULD SIMPLIFY DME UPGRADE PURCHASES; FINANCE COMMITTEE APPROVES PART B COMPETITIVE BIDDING, 37.5% OXYGEN PAYMENT CUT

This article was originally published in The Gray Sheet

Executive Summary

Purchasing of upgraded or enhanced durable medical equipment would be simplified under the Medicare bill unanimously approved by the Senate Finance Committee June 18. The provision would make it easier for beneficiaries to buy higher-end DME by incurring only the difference in cost between the upgrade and the standard model as an out-of-pocket expense, with DME suppliers being reimbursed for the cost of the standard item.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008296

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel